Le Lézard
Classified in: Health, Science and technology
Subject: FDA

PathKeeper Surgical Receives FDA 510k Clearance for Spine Navigation System


PathKeeper improves clinical experience and reduces the reliance on radiation in spine surgery

KFAR SABA, Israel, June 15, 2023 /PRNewswire-PRWeb/ -- PathKeeper Surgical, a privately-held, Israel-based, medical technology company, dedicated to improving the health of individuals around the world suffering from all spinal issues requiring surgery, while making navigation-guided surgery available to any patient in all operating rooms, received its U.S. Federal & Drug Administration (FDA) 510(k) clearance for its PathKeeper, 3D optical navigation system.

"We are excited to reach this important milestone for PathKeeper and the company," expressed Erez Lampert, Chief Executive Officer and Founder. "We now move our focus to commercialization in the United States to make PathKeeper available to all spine surgeons and their patients."

The PathKeeper system was designed to replace traditional navigation technology with a 3D optical navigation system that offers active, real-time, independent tracking of patient anatomy and surgical instruments, accuracy of implantation to less than a millimeter, more efficient surgical workflow, elimination of radiation exposure during the surgical procedure and a more economical price so both hospital and ambulatory-surgical center operating rooms can incorporate this new technology.

"There is a definite need for a new navigation system that is adaptable and easily integrated into operating rooms. PathKeeper took that challenge and created a spine navigation system that is easily operated, offers real-time tracking and eliminates radiation exposure during the procedure. This is the new standard of care," explained Tushar Patel, MD, Washington Orthopaedics & Sports Medicine, Chevy Chase, MD.

PathKeeper Surgical received its FDA 510k clearance earlier this year for the PathKeeper system. The name PathKeeper effectively describes the essence of the system - a 3D optical navigation system that 'keeps' the surgical 'path' on course throughout the surgery.

About PathKeeper Surgical

PathKeeper Surgical is an Israeli-based, medical technology company that has established a solution to combat the high failure rates seen in spinal surgeries. PathKeeper was founded in 2018 by Erez Lampert, a top 3D medical imaging expert with more than 20 years of experience in the healthcare and aerospace industries, and a proven track record in the field of 3D imaging. Erez previously served as the R&D leader for the Itero Element Intraoral Scanner for Align Technology (Invisalign), the leading 3D dental scanner in the world today. Josh Schroeder, MD, the Director of Spinal Deformities at Hadassah Medical Center and a HSS fellow, has been onboard since the inception of the company as a clinical advisor. Erez and Josh's combined knowledge enabled the company to develop an innovative navigation system that outperforms existing solutions. Learn more at path-keeper.com.

Pull Quote

"PathKeeper created a spine navigation system that is easily operated, offers real-time tracking and eliminates radiation exposure during the procedure," Tushar Patel, MD.

Media Contact

Ryan LeBlanc, PathKeeper Surgical, 1 (860) 334-6493, [email protected], path-keeper.com

 

SOURCE PathKeeper Surgical


These press releases may also interest you

at 16:55
Revelation Biosciences, Inc. (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three months ended March...

at 16:35
Bristol Myers Squibb today announced the Phase 3 CheckMate -73L trial did not meet its primary endpoint of progression-free survival (PFS) in unresectable, locally advanced stage III non-small cell lung cancer (NSCLC). CheckMate -73L evaluated...

at 16:35
Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung...

at 16:35
Merrimack Pharmaceuticals, Inc. ("Merrimack" or the "Company") announced that the stockholders at a Special Meeting held today overwhelmingly approved adopting a Plan of Dissolution. Following that announcement, the Board of Directors declared a...

at 16:30
LivePerson, Inc. is providing confirmatory notice, in compliance with the requirements of Nasdaq Listing Rule 5635(c)(4), of recent grants of equity-based incentive awards that LivePerson made under the LivePerson Inc. 2018 Inducement Plan (the...

at 16:20
Getaround ("Getaround'' or "the Company"), the world's first connected carsharing marketplace, today announced three new additions to its Board of Directors. Nikul Patel, Neil Savage and Qais Sharif effective May 6, 2024. They will join existing...



News published on and distributed by: